HK1030361A1 - 8-chloro-6, 11-dihydro-11-(4-piperidylidine)-5h-benzo (5,6) cyclohepta (1,2-b)pyridine oral compositions - Google Patents

8-chloro-6, 11-dihydro-11-(4-piperidylidine)-5h-benzo (5,6) cyclohepta (1,2-b)pyridine oral compositions

Info

Publication number
HK1030361A1
HK1030361A1 HK01100972A HK01100972A HK1030361A1 HK 1030361 A1 HK1030361 A1 HK 1030361A1 HK 01100972 A HK01100972 A HK 01100972A HK 01100972 A HK01100972 A HK 01100972A HK 1030361 A1 HK1030361 A1 HK 1030361A1
Authority
HK
Hong Kong
Prior art keywords
piperidylidine
cyclohepta
benzo
dihydro
pyridine
Prior art date
Application number
HK01100972A
Other languages
English (en)
Inventor
Jim H Kou
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1030361(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK1030361A1 publication Critical patent/HK1030361A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK01100972A 1998-07-10 2001-02-10 8-chloro-6, 11-dihydro-11-(4-piperidylidine)-5h-benzo (5,6) cyclohepta (1,2-b)pyridine oral compositions HK1030361A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10
PCT/US1999/012368 WO2000002560A1 (en) 1998-07-10 1999-07-08 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE ORAL COMPOSITIONS

Publications (1)

Publication Number Publication Date
HK1030361A1 true HK1030361A1 (en) 2001-05-04

Family

ID=22348307

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100972A HK1030361A1 (en) 1998-07-10 2001-02-10 8-chloro-6, 11-dihydro-11-(4-piperidylidine)-5h-benzo (5,6) cyclohepta (1,2-b)pyridine oral compositions

Country Status (28)

Country Link
EP (3) EP1380297B1 (xx)
JP (4) JP3224379B1 (xx)
KR (1) KR100420641B1 (xx)
CN (1) CN1145485C (xx)
AR (4) AR016044A1 (xx)
AT (2) ATE432075T1 (xx)
AU (1) AU741201B2 (xx)
BR (1) BR9910449A (xx)
CA (2) CA2325014C (xx)
CY (1) CY1109279T1 (xx)
CZ (1) CZ300843B6 (xx)
DE (2) DE69940932D1 (xx)
DK (2) DK1380297T3 (xx)
ES (2) ES2214871T3 (xx)
HK (1) HK1030361A1 (xx)
HU (1) HU228448B1 (xx)
ID (1) ID28645A (xx)
IL (1) IL139407A0 (xx)
MY (1) MY116038A (xx)
NO (1) NO331454B1 (xx)
NZ (2) NZ512916A (xx)
PE (1) PE20000761A1 (xx)
PL (1) PL199390B1 (xx)
PT (2) PT1380297E (xx)
SK (1) SK288240B6 (xx)
TW (1) TW575424B (xx)
WO (1) WO2000002560A1 (xx)
ZA (1) ZA200006224B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
MX2007000632A (es) * 2004-07-16 2007-03-30 Cipla Ltd Composicion antihistaminica.
JP5161070B2 (ja) 2006-03-31 2013-03-13 財団法人乙卯研究所 ヘテロ環を有する新規化合物
CN101868228B (zh) 2007-11-21 2016-12-07 大日本住友制药株式会社 口腔内崩解片
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
WO2011141483A2 (en) 2010-05-10 2011-11-17 Laboratorios Lesvi, S.L. Stable pharmaceutical formulations containing an antihistaminic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61501205A (ja) 1984-02-15 1986-06-19 シェリング・コ−ポレ−ション ８↓−クロル↓−６，１１↓−ジヒドロ↓−１１↓−（４↓−ピペリジリデン）↓−５Ｈ↓−ベンゾ〔５，６〕シクロヘプタ〔１，２−ｂ〕ピリジンおよびその塩、これらの化合物の製造方法、ならびにこれらの化合物を含有する医薬組成物
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra

Also Published As

Publication number Publication date
TW575424B (en) 2004-02-11
MY116038A (en) 2003-10-31
JP2002068983A (ja) 2002-03-08
EP2055303A3 (en) 2009-12-16
ES2214871T3 (es) 2004-09-16
IL139407A (en) 2001-10-31
HUP0101900A3 (en) 2003-01-28
AR021159A1 (es) 2002-06-12
ATE262904T1 (de) 2004-04-15
NO331454B1 (no) 2012-01-09
PL344045A1 (en) 2001-09-24
DE69916042T2 (de) 2004-11-11
JP2005298524A (ja) 2005-10-27
DK1380297T3 (da) 2009-08-17
KR20010043402A (ko) 2001-05-25
NO20005485D0 (no) 2000-10-31
ATE432075T1 (de) 2009-06-15
CA2325014C (en) 2002-05-28
AR021158A2 (es) 2002-06-12
ID28645A (id) 2001-06-21
AU4953199A (en) 2000-02-01
ZA200006224B (en) 2001-11-01
JP4160739B2 (ja) 2008-10-08
SK288240B6 (sk) 2015-02-03
AR021157A2 (es) 2002-06-12
PL199390B1 (pl) 2008-09-30
PT1380297E (pt) 2009-07-06
WO2000002560A1 (en) 2000-01-20
PT1073438E (pt) 2004-07-30
EP1073438B1 (en) 2004-03-31
EP1380297B1 (en) 2009-05-27
JP2002520285A (ja) 2002-07-09
CN1303284A (zh) 2001-07-11
AR016044A1 (es) 2001-06-20
CA2325014A1 (en) 2000-01-20
PE20000761A1 (es) 2000-08-31
NZ512916A (en) 2003-03-28
DE69916042D1 (de) 2004-05-06
SK17112000A3 (sk) 2001-12-03
EP1073438A1 (en) 2001-02-07
JP3224379B1 (ja) 2001-10-29
BR9910449A (pt) 2001-01-02
JP4621082B2 (ja) 2011-01-26
DE69940932D1 (de) 2009-07-09
NZ507885A (en) 2001-08-31
DK1073438T3 (da) 2004-05-10
CY1109279T1 (el) 2012-05-23
EP2055303A2 (en) 2009-05-06
CZ20004056A3 (cs) 2001-03-14
JP2010265329A (ja) 2010-11-25
KR100420641B1 (ko) 2004-03-02
HU228448B1 (en) 2013-03-28
ES2326214T3 (es) 2009-10-05
NO20005485L (no) 2001-03-09
HUP0101900A2 (hu) 2001-11-28
EP1380297A1 (en) 2004-01-14
CA2377178A1 (en) 2000-01-20
IL139407A0 (en) 2001-11-25
CZ300843B6 (cs) 2009-08-26
AU741201B2 (en) 2001-11-22
CN1145485C (zh) 2004-04-14

Similar Documents

Publication Publication Date Title
SI1129088T1 (sl) Kristalinična oblika (R)-2(((3-metil-4-(2,2,2-trifluoroetoksi)-2-piridinil)metil)sulfinil)- 1H-benzimidazola
AU3993885A (en) 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
NZ222253A (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo c5,6,)cyclohepta c1,2-b)pyridine derivatives and pharmaceutical compositions
PL337712A1 (en) Polymorphous form of 8-chloro-6, 11-dihydro-11-94-piperydilene) -5h-benzo[5,6]cyclohepta [1,2-b] pyridine
HK1030361A1 (en) 8-chloro-6, 11-dihydro-11-(4-piperidylidine)-5h-benzo (5,6) cyclohepta (1,2-b)pyridine oral compositions
AU2003230758A1 (en) 5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
IL133449A0 (en) Benzo (5, 6) cyclohepta (1, 2-b) pyridine derivatives as farnesyl protein transferase inhibitors
AU9683798A (en) Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo{5,6}cyclohepta {1,2-b}pyridin -11-ylidene)-1- piperidene carboxylate polymorph
NZ231726A (en) 6,11 dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridines and pharmaceutical compositions
ZA877919B (en) 6,11-dihydro-11-(4-piperidylidene)-5h-benzo(5,6)cyclohepta(1,2-b)pyridines and compositions and methods of use
ES2087026A1 (es) Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina.
HK1034510A1 (en) Improved omeprazole process and compositions thereof

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20190707